BIRC5 and oral cavity squamous cell carcinoma: In contrast, few studies have reported immunohistochemical cytoplasmic survivin expression as an unfavorable factor in patients with colorectal cancer [30], pancreatic cancer [35], or oral squamous cell carcinoma [21].